Evidence map›Paper›PMID 24302757›Full record

ArticleThe Journal of infectious diseases2014

Natural cytotoxicity receptor-dependent natural killer cytolytic activity directed at hepatitis C Virus (HCV) is associated with liver inflammation, African American race, IL28B genotype, and response to pegylated interferon/ribavirin therapy in chronic HCV infection.

Qinglai Meng, M R Sandhya Rani, Julia M Sugalski, Chelsey J Judge, Sarah Phat, Benigno Rodriguez, Ronald E Blanton, Donald D Anthony

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. CD56Journal of leukocyte biology · 2017
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Qinglai MengDepartment of Medicine.
M R Sandhya Rani
Julia M Sugalski
Chelsey J Judge
Sarah Phat
Benigno Rodriguez
Ronald E Blanton
Donald D Anthony
Case Western Reserve University · USUniversity Hospitals Case Medical Center · US

Funding

Host Genetic Contribution to HCV OutcomesR01AI073963 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BLANTON, RONALD E · 2008 to 2011
$2.1M
Recurrent treatment: Effect on rural and urban S. mansoni population structureR01AI069195 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BLANTON, RONALD E · 2007 to 2011
$1.8M
Role of immature DC in host defense against HCVR01DK068361 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI ANTHONY, DONALD D · 2006 to 2010
$1.3M
Role of IL28B and HIV in NK Control of HCVR21AI100809 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI ANTHONY, DONALD D · 2012 to 2013
$420k
Role of NK cells in control of HCV infection associated hepatocellular carcinomaI01BX001894 · VA · LOUIS STOKES CLEVELAND VA MEDICAL CENTER · PI Donald D Anthony · 2013 to 2026
–
BLRD VA I01 BX001894NIAID NIH HHS R01 AI069195NIAID NIH HHS R01 AI073963NIAID NIH HHS R01 AI100809-01NIAID NIH HHS R21 AI100809NIDDK NIH HHS R01 DK068361
6 · The paper itself

Abstract

backgroundNatural killer (NK) cells are implicated in the pathogenesis of hepatitis C virus (HCV) infection and outcome of interferon (IFN)-α based therapy, although mechanisms remain unclear.

methodsTo evaluate NK ability to control HCV infection, we analyzed healthy donor and HCV-infected donor NK-cell cytolytic activity directed at HCV-infected target cells.

resultsHCV-infected subjects' natural cytotoxicity receptor (NCR)-dependent NK-cell cytolytic activity directed at HCV-infected and uninfected Huh7.5 target cells was greater than that of cells from healthy donors, and this localized to the African American subset. However, IFN-α-enhanced NK cytolytic function was lower in HCV-infected subjects, again localized mainly to the African American subset. Additionally, whereas HCV-infected Huh7.5 cells were more readily targeted than uninfected cells, the selectivity of cytolytic activity for infected targets was lower during HCV infection and after IFN-α stimulation, and lower selectivity was in part attributable to greater NKp46 expression. Furthermore, cytolytic activity was associated with higher serum aspartate aminotransferase, rs12979860 IL28B genotype, and in vivo response to pegylated IFN/ribavirin therapy.

conclusionsThese data indicate that during chronic HCV infection, race-associated increase in NCR expression and IL28B-associated cytolytic activity may participate in host response to IFN-α-containing HCV therapy.

Indexed as

AdultAntiviral AgentsBlack or African AmericanFemaleGene Expression RegulationHepacivirusHepatitis CHumansInterferon-alphaInterferon alpha-2Interferon LambdaInterferonsInterleukinsKiller Cells, NaturalLiver DiseasesLysosomal-Associated Membrane Protein 1Antiviral AgentsInterferon-alphaInterferon alpha-2Interferon Lambdainterferon-lambda, humanInterferonsInterleukinsLysosomal-Associated Membrane Protein 1peginterferon alfa-2bPolyethylene GlycolsRecombinant ProteinsRibavirinhepatitis Chumaninfectionlivernatural killer

Identifiers

PMID24302757
PMCPMC3997579
OpenAlexW2168512887

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.